Sanara MedTech (NASDAQ:SMTI) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.04) by 225 percent. This is a 112.2 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $27.799 million which beat the analyst consensus estimate of $26.800 million by 3.73 percent. This is a 18.65 percent increase over sales of $23.430 million the same period last year.